Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 11-20 of 97 (Search time: 0.004 seconds).
previous
1
2
3
4
5
...
10
next
Item hits:
Preview
Issue Date
Title
Author(s)
2007
Monitoring disease response
Hughes, T.
;
Branford, S.
;
Melo, J.
;
Goldman, J.
2010
Limiting the variability within a BCR-ABL quantitative PCR (RQ-PCR) assay is essential for optimal concordance of results between laboratories generating BCR-ABL values on an international reporting scale
Fletcher, L.
;
Prime, J.
;
Phillis, S.
;
Jamison, B.
;
Field, C.
;
Prime, H.
;
Sullivan, B.
;
Yeoman, A.
;
Georgievski, J.
;
Parker, W.
;
Slader, C.
;
Hughes, T.
;
Branford, S.
;
Haematology Association of Australasia Annual Meeting (2010 : Auckland, New Zealand)
2014
The adverse effect of high sokal risk for first line imatinib treated patients is overcome by a rapid rate of BCR-ABL decline measured as early as 1 month of treatment
Branford, S.
;
Yeung, D.
;
Ross, D.
;
Parker, W.
;
Braley, J.
;
Seymour, J.
;
Hughes, T.
;
56th ASH Annual Meeting (6 Dec 2014 - 9 Dec 2014 : San Francisco, California)
2012
Continued therapeutic response monitoring in optimal responders with CML
Branford, S.
2012
Monitoring disease response in chronic-phase chronic myeloid leukemia: the age of molecular assays?
Yeung, D.
;
Branford, S.
2013
PCR-mediated recombination can lead to artificial chimera formation, which may pose as BCR-ABL1 compound mutations
Parker, W.
;
Phillis, S.
;
Yeung, D.
;
Hughes, T.
;
Scott, H.
;
Branford, S.
;
55th American Society of Hematology Annual Meeting and Exhibition (7 Dec 2013 - 10 Dec 2013 : New Orleans, Louisiana)
2019
The hidden pathogenesis of CML: is BCR-ABL1 the first event?
Shanmuganathan, N.
;
Branford, S.
2022
Multiplex technologies for the assessment of minimal residual disease and low-level mutation detection in leukaemia: mass spectrometry versus next-generation sequencing
Shanmuganathan, N.
;
Branford, S.
2007
Reliability of PCR for BCR-ABL transcripts
Hughes, T.
;
Branford, S.
;
Goldman, J.
2017
CRISPR-Cas9-mediated saturated mutagenesis screen predicts clinical drug resistance with improved accuracy
Ma, L.
;
Boucher, J.
;
Paulsen, J.
;
Matuszewski, S.
;
Eide, C.
;
Ou, J.
;
Eickelberg, G.
;
Press, R.
;
Zhu, L.
;
Druker, B.
;
Branford, S.
;
Wolfe, S.
;
Jensen, J.
;
Schiffer, C.
;
Green, M.
;
Bolon, D.
Discover
Author
61
Hughes, T.
17
Ross, D.
17
Yeung, D.
16
Radich, J.
15
Shanmuganathan, N.
14
Hochhaus, A.
12
Hughes, T.P.
10
Grigg, A.
10
Parker, W.
10
Seymour, J.
.
next >
Subject
36
Humans
35
Leukemia, Myelogenous, Chronic, B...
25
Fusion Proteins, bcr-abl
22
Pyrimidines
21
Benzamides
21
Piperazines
20
Imatinib Mesylate
15
Male
15
Middle Aged
14
Adult
.
next >
Date issued
16
2020 - 2023
55
2010 - 2019
25
2000 - 2009
1
1999 - 1999